Influence of Suppressor of Cytokine Signaling 1 (SOCS1) Gene Variations on Polycystic Ovary Syndrome

被引:0
作者
Rakhshanizade, Niloufar [1 ]
Sargazi, Saman [2 ,3 ]
Karajibani, Mansour [1 ,4 ]
Majidpour, Mahdi [5 ]
Karajibani, Atena [6 ]
Montazerifar, Farzaneh [1 ,4 ]
Ghasemi, Marzieh [7 ,8 ]
机构
[1] Zahedan Univ Med Sci, Sch Med, Dept Nutr, Zahedan, Iran
[2] Zahedan Univ Med Sci, Res Inst Cellular & Mol Sci Infect Dis, Cellular & Mol Res Ctr, Zahedan, Iran
[3] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran
[4] Zahedan Univ Med Sci, Hlth Promot Res Ctr, Zahedan, Iran
[5] Zahedan Univ Med Sci, Clin Immunol Res Ctr, Zahedan, Iran
[6] Univ Sistan & Baluchestan, Dept Biol, Zahedan, Iran
[7] Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran
[8] Zahedan Univ Med Sci, Ali ibn Abitaleb Hosp, Moloud Infertil Ctr, Zahedan, Iran
关键词
SOCS1; Gene polymorphism; Polycystic ovarian syndrome; Cytokine signaling; INSULIN-RESISTANCE; ASSOCIATION; POLYMORPHISMS; EXPRESSION; CRITERIA; PREVALENCE; PHENOTYPES; VARIANTS; PCOS;
D O I
10.1007/s12291-024-01248-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycystic ovarian syndrome (PCOS) is associated with low-grade systemic inflammation and an increase in inflammation markers, which are crucial in managing ovarian function. This study aimed to determine whether SOCS1 gene variants are associated with PCOS risk. In total, 300 subjects were enrolled (150 patients with PCOS and 150 healthy individuals). Each subject's peripheral blood was collected for genomic DNAs isolation and biochemical assessments. After adjustment for BMI, codominant heterozygous [OR = 0.45, 95%CI = 0.27-0.77], codominant homozygous [OR = 0.29, 95%CI = 0.11-0.76], dominant [OR = 0.39, 95%CI = 0.23-0.65], and overdominant [OR = 0.50, 95%CI = 0.29-0.84] models of rs33932899, as well as the codominant homozygous [OR = 0.26, 95%CI = 0.10-0.69], dominant [OR = 0.55, 95%CI = 0.34-0.89], and recessive [OR = 0.33, 95%CI = 0.12-0.87] genetic patterns of rs243327 were significantly associated with decreased PCOS risk. On the contrary, codominant homozygous [OR = 2.40, 95%CI = 1.20-4.78] and recessive [OR = 2.10, 95%CI = 1.14-3.87] modes of the rs33989964 variation increased PCOS risk (P-value < 0.05). Analysis of the interaction demonstrated that the GG/Del-Del/CC genotype combination of rs33932899/rs33989964/rs243327 significantly increased the risk of PCOS in our population [OR = 4.81, 95%CI = 1.72-13.49]. Furthermore, the G(rs33932899)TG(rs33989964)C(rs243327) and C(rs33932899)Del(rs33989964)C(rs243327) and C(rs33932899)Del(rs33989964)T(rs243327) haplotypes were associated with the risk of PCOS (p = 0.007, p < 0.001 and p = 0.012 respectively). A significant difference has also been observed between cases carrying GG + GC genotypes of rs33932899 regarding fasting blood sugar levels (P-value < 0.05). The SOSC1 rs33989964 variation increased PCOS risk, while both SOSC1 rs33932899 and rs243327 variants conferred protection against PCOS in our population. Additional research on various racial groups is needed to determine if these variations contribute to PCOS, a complicated hormonal disorder with multiple factors. [GRAPHICS]
引用
收藏
页数:10
相关论文
共 53 条
[1]   Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update [J].
Abraham Gnanadass, Subeka ;
Divakar Prabhu, Yogamaya ;
Valsala Gopalakrishnan, Abilash .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (03) :631-643
[2]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[3]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[4]   Involvement of SOCS-1, the suppressor of cytokine signaling, in the prevention of prolactin-responsive gene expression in decidual cells [J].
Barkai, U ;
Prigent-Tessier, A ;
Tessier, C ;
Gibori, GB ;
Gibori, G .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (04) :554-563
[5]   Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses [J].
Biglari-Zadeh, Ghazaleh ;
Sargazi, Saman ;
Mohammadi, Malihe ;
Ghasemi, Marzieh ;
Majidpour, Mahdi ;
Saravani, Ramin ;
Mirinejad, Shekoufeh .
BIOCHEMICAL GENETICS, 2023, 61 (05) :1827-1849
[6]   Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus [J].
Chan, H. C. ;
Ke, L. Y. ;
Chang, L. L. ;
Liu, C. C. ;
Hung, Y. H. ;
Lin, C. H. ;
Li, R. N. ;
Tsai, W. C. ;
Liu, H. W. ;
Yen, J. H. .
LUPUS, 2010, 19 (06) :696-702
[7]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[8]  
Chen SS, 2020, EUR REV MED PHARMACO, V24, P5564, DOI 10.26355/eurrev_202005_21342
[9]   Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta [J].
Choi, Yong Seok ;
Park, Jin Kyun ;
Kang, Eun Ha ;
Lee, Young-Kyun ;
Kim, Tae Kyun ;
Chung, Jin-Haeng ;
Zimmerer, Jason M. ;
Carson, William E., III ;
Song, Yeong Wook ;
Lee, Yun Jong .
ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
[10]   Suppressors of cytokine signaling (SOCS): Inhibitors of the JAK/STAT pathway [J].
Cooney, RN .
SHOCK, 2002, 17 (02) :83-90